my view - I don’t think that the sept ARDS read out will result in the trial stopped due to overwhelming efficiency (due to a lesser difference in control mortality). That’s the first warning flag that the results may be more marginal than expected.
IMO - in an election year if Remestemcel-L shows even 50% efficacy against even a 30% mortality in the control group, there would be some pressure to give it Emergency Approval (even if it is only for a few months) ... people are still dying in large numbers each day .... something has to be done ..... just my opinion so don't go running out buying shares on what I have posted
# Country,Other TotalCases NewCases TotalDeaths NewDeaths TotalRecovered ActiveCases Serious,Critical Tot Cases/1M pop Deaths/1M pop TotalTests Tests/1M pop Population 1 World 20,492,185 +246,615 744,074 +5,772 13,412,331 6,335,780 64,556 2,629 95.5 2 1 USA 5,303,081 +51,643 167,499 +1,307 2,744,561 2,391,021 17,473 16,011 506 66,910,646 202,013 331,219,304
Anyone else buy in after todays dip/crash?, page-164
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.5¢ |
Change
-0.025(2.45%) |
Mkt cap ! $1.136B | |||
| Open | High | Low | Value | Volume |
| $1.02 | $1.04 | 99.5¢ | $4.379M | 4.328M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 163238 | 99.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 19700 | 2 |
View Market Depth
| Last trade - 16.10pm 01/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |